Use of PCR Cycle Threshold and Clinical Interventions to Aid in the Management of Pediatric Clostridioides difficile Patients

被引:0
|
作者
Suleiman, Mohammed [1 ]
Tang, Patrick [1 ,2 ]
Imam, Omar [3 ]
Morales, Princess [1 ]
Altrmanini, Diyna [1 ]
Barr, Kelli L. [4 ]
Roberts, Jill C. [4 ]
Perez-Lopez, Andres [1 ,2 ]
机构
[1] Sidra Med, Dept Pathol, POB 26999, Doha, Qatar
[2] Weill Cornell Med Qatar, Dept Pathol & Lab Med, POB 24144, Doha, Qatar
[3] Sidra Med, Dept Infect Prevent & Control, POB 26999, Doha, Qatar
[4] Univ S Florida, Ctr Global Hlth & Infect Dis Res, Tampa, FL 33612 USA
关键词
Clostridioides difficile; pediatric; children; cycle threshold; intervention; INFECTION; IMPACT; EPIDEMIOLOGY; DIAGNOSIS; PREDICTS; CHILDREN;
D O I
10.3390/microorganisms12061181
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Better diagnostic tools are needed to improve the diagnosis of Clostridioides difficile infections (CDI) and reduce the overtreatment of colonized children. In this study, we evaluated two polymerase chain reaction (PCR) assays (Cepheid GeneXpert C. difficile and the Gastroenteritis PCR Panel by QIAstat-Dx) as a standalone method in combination with the PCR cycle threshold (Ct) value in positive samples to predict the presence of free toxins. We also evaluated the clinical impact of reporting toxin production results and provided comments alongside the PCR results in our pediatric population. PCR-positive stool samples from pediatric patients (aged 2 to 18 years old) were included in our study and tested for the presence of toxins A and B using the C. difficile Quik Chek Complete kit. For the clinical intervention, the CDI treatment rates 6 months pre- and post-intervention were compared. The use of PCR Ct value showed excellent sensitivity (100%) at a Ct value cutoff of 26.1 and 27.2 using the Cepheid GeneXpert C. difficile and the Gastroenteritis PCR Panel by QIAstat-Dx, respectively, while the toxin test showed inferior sensitivity of 64% in the PCR-positive samples. In addition, CDI treatment rates were decreased by 23% post-intervention. The results of our study suggest that nucleic acid amplification test (NAAT) assays supplemented by the use of PCR Ct value for positive samples can be used as standalone tests to differentiate CDI from colonization. Furthermore, the reporting of toxin production along with the PCR results can help reduce the unnecessary treatment of colonized children.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] PCR cycle threshold value predicts the course of Clostridium difficile infection
    Jazmati, N.
    Hellmich, M.
    Licanin, B.
    Plum, G.
    Kaasch, A. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (02) : E7 - E8
  • [22] Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients
    Conover, Katie R.
    Absah, Imad
    Ballal, Sonia
    Brumbaugh, David
    Cho, Stanley
    Cardenas, Maria C.
    Knackstedt, Elizabeth Doby
    Goyal, Alka
    Jensen, M. Kyle
    Kaplan, Jess L.
    Kellermayer, Richard
    Kociolek, Larry K.
    Michail, Sonia
    Oliva-Hemker, Maria
    Reed, Anna W.
    Weatherly, Madison
    Kahn, Stacy A.
    Nicholson, Maribeth R.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 76 (04): : 440 - 446
  • [23] THE GUT MICROBIOME AND ASSOCIATED CLOSTRIDIOIDES DIFFICILE COLONIZATION IN PEDIATRIC CANCER PATIENTS
    Willis, Daniel
    Tao, Yu
    Luo, Jingquin
    Hayashi, Robert
    Storch, Gregory
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S95 - S95
  • [24] Management and Outcomes of Patients at a Specialty Clinic for Clostridioides difficile Infection
    Hunt, Aaron
    Danziger, Larry H.
    Johnson, Stuart
    Skinner, Andrew M.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (04):
  • [25] Management of Clostridioides difficile infection in patients with inflammatory bowel disease
    Khanna, Sahil
    INTESTINAL RESEARCH, 2021, 19 (03) : 265 - 274
  • [26] Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic Clostridioides difficile
    Suarez-Carantona, Cecilia
    Rodriguez-Torres, Argeme
    Viteri-Noel, Adrian
    Pintado, Vicente
    Garcia-Fernandez, Sergio
    Mora-Pimentel, Daniel
    Escudero-Sanchez, Rosa
    Martin-Jusdado, Fuencisla
    Moreno, Santiago
    Cobo, Javier
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [27] Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection
    Kunishima, Hiroyuki
    Ohge, Hiroki
    Suzuki, Hiromichi
    Nakamura, Atsushi
    Matsumoto, Kazuaki
    Mikamo, Hiroshige
    Mori, Nobuaki
    Morinaga, Yoshitomo
    Yanagihara, Katsunori
    Yamagishi, Yuka
    Yoshizawa, Sadako
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (08) : 1045 - 1083
  • [28] Holding firm: Use of clinical correlation to improve Clostridioides difficile testing
    Baghdadi, Jonathan
    Ganz, David A.
    Chumpia, Maryanne
    Chang, Evelyn T.
    de Peralta, Shelly S.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2020, 48 (09) : 1104 - 1107
  • [29] Outcomes of clinical decision support for outpatient management of Clostridioides difficile infection
    Wu, Tiffany
    Davis, Susan L.
    Church, Brian
    Alangaden, George J.
    Kenney, Rachel M.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (10): : 1345 - 1348
  • [30] Efficacy of a stewardship intervention focused on reducing unnecessary use of non-Clostridioides difficile antibiotics in patients with Clostridioides difficile infection
    Hecker, Michelle T.
    Son, Andrea H.
    Alhmidi, Heba
    Wilson, Brigid M.
    Wiest, Peter M.
    Donskey, Curtis J.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (02): : 216 - 218